About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Performance of a New Glucose Meter System | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01264016

Performance of a New Glucose Meter System

The purpose of this study is to evaluate the performance and acceptability of a new blood glucose monitoring system, which includes meter and sensor strip.

Lead sponsor: Ascensia Diabetes Care•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ascensia Diabetes Care

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Type 1 or 2 diabetes
•Age 18 years or older
•Routinely performs blood glucose self testing at home, at least once per day
•Able to speak, read, and understand English.
•Is willing to complete all study procedures

Exclusion Criteria

•Currently pregnant
•Hemophilia or any other bleeding disorder
•Taking prescription anticoagulants or has clotting problems that may prolong bleeding. Taking aspirin daily is not excluded
•Subject employee of competitive medical device company
•Cognitive disorder or other condition, which in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study

Related studies

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

NCT06893341 · Diabetes, Hyperglycemia, and more

Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD

NCT07187830 · Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT06310356 · Gestational Diabetes

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 29, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment96

Start dateNov 2010

Last updatedFeb 29, 2016

Condition

Locations shown

AMCR Institute

Escondido, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions